Comment · Mon, May 9, 2016 · Ceretropic & Nootropics Depot
Why is there such little information on N-Acetyl Semax Amidate or N-Acetyl Selank?
What they were answering
Noobsessed · 1 points
I understand, but there is still a the possibility that an acetylated version of semax was already tested and disregarded for one reason or the other, especially when it was already common to acetylate compounds to improve its efficiency. I don't doubt that your reasoning is solid and people taking NAS and NASA confirm its safety, at least. I am still buying your regular semax again, as I'm a total chicken.
Have you thought of making scientific studies with those versions or are you planning to do so in the future? I am not aware of it so if it has been discussed already I'll just read the post. Wouldn't it be possible to patent those compounds?
u/MisterYouAreSoDumb · Ceretropic & Nootropics Depot
I understand, but there is still a the possibility that an acetylated version of semax was already tested and disregarded for one reason or the other, especially when it was already common to acetylate compounds to improve its efficiency.
They would have written about it, had that been the case. Scientists don't go through the whole effort of studying modifications to compounds, and then not publish those results. Remember, nobody was talking about Semax in the west till we made it more popular and accessible. So it's not like piracetam, where countless studies have been run on it, and a bunch of analogs already found. Very few people in the west had even used Semax a couple years ago, much less thought about improving it. So it is not surprising that there is not a lot of data.
Have you thought of making scientific studies with those versions or are you planning to do so in the future?
Yes, we plan to. It just takes a lot more time and effort talking someone qualified into spending the time to research it.
Wouldn't it be possible to patent those compounds?
No, I have already talked about them and made them public. They no longer have novelty. So nobody can patent them, just like nobody can patent any of Alexander Shulgin's compounds he synthesized and talked about. Once a chemical structure is made public/published, it no longer has novelty from a patent standpoint. On the same token, if a chemical structure is even mentioned in a paper, whether that be as an intermediate or in passing, that chemical structure no longer has novelty either. That's why you see companies pushing for new chemical compounds, rather than improving existing ones.